Hetero Drugs
Corporate brand
UnclaimedLeading Indian generic pharmaceutical manufacturer.
Last updated August 25, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Hetero Drugs is one of India's major generic pharmaceutical manufacturers, producing antiretrovirals, antimalarials, and exporting to many countries.
Recent events
Reported
Hetero launches Favivir 800/200 pack[1]
Hetero said it launched Favivir 800/200, a pack of its generic oral antiviral favipiravir drug for mild-to-moderate symptomatic COVID-19 patients in India. The pack contains 16 tablets of 800 mg and two tablets of 200 mg and is priced at Rs 2,640.
Reported
Hetero launches Favivir generic Favipiravir in India[2]
Hetero launched Favivir, its generic Favipiravir, in India after receiving manufacturing and marketing approval from the Drug Controller General of India. The drug is prescription-only and priced at ₹59 per tablet.
Reported
Hetero launches Favivir in India[3]
Hetero said it launched Favivir, a generic oral antiviral drug for patients with mild to moderate COVID-19, in India at Rs 59 per tablet. The product was available from July 29, 2020, by prescription.
Reported
Hetero receives approval for generic remdesivir[4]
India’s Drug Controller-General approved Hetero to manufacture and sell its generic version of Gilead’s remdesivir for treating COVID-19 patients in India.
Reported
Hetero launches Taffic in India[5]
Hetero launched Taffic, a three-in-one antiretroviral combination drug used to treat HIV-1, in India. Hetero Healthcare will market and distribute the product in the country.
Sources5 sources
Cite this profile: Cite the canonical profile. /brand-wiki/hetero-drugs · Editorial policy · How profiles are compiled